Tag: Stimwave
Former Stimwave CEO hit with fraud charges over ‘fake, non-functional’ device...
The US Securities and Exchange Commission (SEC) has today charged Laura Tyler Perryman—the former chief executive officer (CEO) and co-founder of Florida-based medical device...
Stimwave announces sale of business and secures US$40 million in financing
Stimwave Technologies Incorporated (Stimwave) recently announced that it has reached an agreement to sell substantially all of its assets to Kennedy Lewis Management LP...
Stimwave launches FREEDOM series with trial evaluating PNS in chronic knee...
Stimwave Technologies has announced the launch of its level-one FREEDOM clinical trial series—which consists of multicentre, prospective, randomised trials that monitor chronic pain patients’...
Stimwave Technologies provides update on reimbursement of chronic pain therapies
Stimwave Technologies has provided an update on recent reimbursement-related progress pertaining to its chronic pain therapies—which include implantable spinal cord stimulation (SCS) and peripheral...
Stimwave launches post-market peripheral neuropathy pain relief randomised controlled trial
In honour of September Pain Awareness Month, Stimwave has announced the launch of a new randomised clinical trial treating painful peripheral neuropathy, known as...
The first wireless spinal cord stimulator system elicits a high response...
A study evaluating different waveforms within a wireless spinal cord stimulator (SCS) device (Stimwave) has found high response rates for patients receiving both high...
Stimwave announces publication of 10 kHz Freedom Stimulator SURF RCT results
Stimwave has announced publication of the results of the first ever randomised, controlled trial (RCT) comparing wireless high-frequency (HF: 10 kHz) spinal cord stimulation...
Stimwave address patent infringement lawsuit brought by Nevro
Stimwave issued a statement today in response to a complaint made by Nevro in Federal Court Delaware District last week alleging Stimwave is infringing...
Nevro files lawsuit for patent infringement against Stimwave
Nevro has announced that it has filed a lawsuit for patent infringement against Stimwave Technologies. The lawsuit, filed in the United States District Court...
Completion of SURF randomised clinical trial of SCS system
Completion of long-term clinical data from the SURF study (Stimwave Technologies) has been announced. The results are now pending publication.
The SURF RCT study,...
Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...
Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...
US FDA clears Stimwave’s full-body MRI-ready wireless peripheral nerve stimulator
Stimwave has received US Food and Drug Administration (FDA) 510(k) clearance for the first wireless, micro-technology neuromodulation device that can enable ongoing full-body MRI...
CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...
CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...
Australian Therapeutic Goods Administration approves Freedom spinal cord stimulation system
The Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for the Freedom Spinal Cord Stimulation (SCS) System (Stimwave). The company launched the product...
